ID: ALA3400958

Max Phase: Preclinical

Molecular Formula: C28H34Cl2N6O3

Molecular Weight: 537.06

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)CCOC(=O)c1ccc2c(c1)c1nc(N3CCC[C@@H](N)C3)n(Cc3ccccc3Cl)c1c(=O)n2C.Cl

Standard InChI:  InChI=1S/C28H33ClN6O3.ClH/c1-32(2)13-14-38-27(37)18-10-11-23-21(15-18)24-25(26(36)33(23)3)35(16-19-7-4-5-9-22(19)29)28(31-24)34-12-6-8-20(30)17-34;/h4-5,7,9-11,15,20H,6,8,12-14,16-17,30H2,1-3H3;1H/t20-;/m1./s1

Standard InChI Key:  ZCGZICPDVICNNU-VEIFNGETSA-N

Associated Targets(Human)

Serum 1292 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Serum 604 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 537.06Molecular Weight (Monoisotopic): 536.2303AlogP: 3.24#Rotatable Bonds: 7
Polar Surface Area: 98.62Molecular Species: BASEHBA: 9HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.88CX LogP: 3.83CX LogD: 0.41
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.36Np Likeness Score: -1.25

References

1. Ikuma Y, Hochigai H, Kimura H, Nunami N, Kobayashi T, Uchiyama K, Umezome T, Sakurai Y, Sawada N, Tadano J, Sugaru E, Ono M, Hirose Y, Nakahira H..  (2015)  Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors: use of a carboxylate prodrug to improve bioavailability.,  23  (4): [PMID:25596166] [10.1016/j.bmc.2014.12.051]

Source